diclofenac has been researched along with Signet Ring Cell Carcinoma in 1 studies
Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.
Excerpt | Relevance | Reference |
---|---|---|
"Gastric cancer has one of the highest incidence rates of cancer worldwide while also contributing to increased drug resistance among patients in clinical practice." | 1.72 | Diclofenac Sensitizes Signet Ring Cell Gastric Carcinoma Cells to Cisplatin by Activating Autophagy and Inhibition of Survival Signal Pathways. ( Dejkriengkraikul, P; Lae Lae Phoo, N; Sukhamwang, A; Yodkeeree, S, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Lae Lae Phoo, N | 1 |
Sukhamwang, A | 1 |
Dejkriengkraikul, P | 1 |
Yodkeeree, S | 1 |
1 other study available for diclofenac and Signet Ring Cell Carcinoma
Article | Year |
---|---|
Diclofenac Sensitizes Signet Ring Cell Gastric Carcinoma Cells to Cisplatin by Activating Autophagy and Inhibition of Survival Signal Pathways.
Topics: Antioxidants; Apoptosis; Autophagy; Carcinoma, Signet Ring Cell; Cisplatin; Cyclin D1; Diclofenac; D | 2022 |